Reiner A. Veitia is a Distinguished Professor of Genetics at the University of Paris Cité. He earned his PhD in Human Genetics from Pasteur Institute and Paris-Diderot University, Paris. He has focused for the last 15 years on the study of ovarian development and function through molecular genetics. This research is carried out through the analysis of different pathologies such as the blepharophimosis syndrome, premature ovarian insufficiency (POI) or ovarian granulosa cell tumors. One of the historical topics of his group is the analysis of the blepharophimosis syndrome, involving craniofacial anomalies and POI, due to alterations of the transcription factor FOXL2. Over the years, he and his team have contributed to a better understanding of its molecular function, pathogenic mechanisms, targets and partners. Prof. Veitia is also investigating the involvement of a specific recurrent somatic mutation of FOXL2 as a driver of adult-type granulosa cell tumors. He and his team have also reported the presence of in-frame insertions in the AKT1 oncogene as likely responsible for juvenile-type granulosa cell tumors. Finally, taking advantage of the power of exome sequencing applied to familial cases of POI they have discovered many genes involved in meiosis whose pathogenic variants are responsible for this condition.

‍

Prof. Veitia is a Honorary member of the Institut Universitaire de France and was awarded one of the Grand Prizes of the French National Academy of Medecine. He is a member of Academia Europaea and of the National Academy of Medecine. He has served as Vice-President of Paris Diderot University for more than 10 years and as Vice-Chairman of its Board of Directors from 2018 till the creation of the University of Paris in January 2020.

‍

Prof. Veitia is the editor-in-chief of the journal Clinical Genetics and a member of the editorial boards of several international journals.